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1. Introduction 
Cervical cancer is a major public health problem. Worldwide, it is the second most common 
cancer in women after breast cancer. Approximately 500,000 new cases of invasive cervical 
cancer have been diagnosed each year with more than 250,000 women dying of the disease. 
It is the most or second most common cancer among women in developing countries. In 
Thailand, a low-resource country, cervical cancer is the second most frequent cause of 
cancer in women, with nearly 10,000 new cases diagnosed and more than 5,200 dying from 
this disease each year (Ferlay et al., 2010). The incidence and mortality have declined during 
the last 50 years in developed countries because of increased availability of cervical cancer 
screening programs (Nieminen et al., 1995). However, cervical cancer continues to be a 
leading cause of cancer deaths in populations with a low socioeconomic level. 
2. Cervical cancer screening 
Screening is the use of methods to distinguish apparently unaffected people from those who 
may have a disease, or may develop it. It is a preliminary process to offer a diagnostic test 
and if required, treatment. Screening test is usually applied on a large scale and are 
generally offered to a population of people who have not sought medical attention on 
account of symptoms of the disease. The purpose of screening is to benefit the individuals 
being screened. Screening procedures are generally easier to perform and cheaper than 
diagnostic procedures. Although the screening test is harmless, it can cause anxiety and the 
subsequent investigations and treatment can be hazardous. Screening methods should 
provide the most attractive combination of negative predictive value (e.g., reassurance) and 
false positives that is attainable in a given setting and providers should ensure that a useful 
remedy is available for all individuals identified as being true positive. 
The most widely used screening method for cervical cancer is conventional cytology 
(conventional Pap smear). Nowadays, conventional cytology is still considered a standard 
screening method worldwide, especially in developing countries. Conventional cytology has 
been being used as a standard screening method for cervical cancer in Siriraj Hospital since 
1952. This cytological testing involves three major steps, i.e. collecting exfoliated cells from 
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the cervix, spreading the cells onto a slide, and microscopically examining these cells after 
staining. Collection of specimens for conventional cytology is performed according to the 
standard vaginal-cervical-endocervical (VCE) smear technique. A wooden (Ayre’s) spatula 
and a cotton swab are used to collect cells from the posterior fornix, portio vaginalis and 
endocervix. The collected cells are then spread onto a glass slide and immediately immersed 
in 95% ethanol for fixation. Despite the proven effectiveness of cervical cytology screening 
in reducing the incidence of cervical cancer, over the last decade the accuracy of cervical 
cytology has been questioned. Two large meta-analyses have indicated that although the 
specificity of conventional cervical cytology is high, its sensitivity is much lower than 
previously estimated (Fahey et al., 1995; Nanda et al., 2000). Errors due to poor sampling 
and partial transferring of the collected sample onto a glass slide, consequently producing a 
nonrepresentative specimen, may account for up to 62% of false negative results (Gay et al., 
1985).  
3. Siriraj liquid-based cytology 
Liquid-based cytology (LBC) was introduced in the mid-1990s as a way to improve 
performance of the test. LBC can improve specimen quality by providing a standardized 
method of collecting cervicovaginal material, and dispersing cells in a thin layer with 
relatively free of inflammation (Austin et al.,1998; Mount et al.,2004; Vassilakos et al.,2002). 
This results in the decrease in incidence of unsatisfactory smears and increase in detection 
rate of cytologic abnormality (Bolick et al.,1998; Corkill et al.,1998; Diaz-Rosario et al.,1999; 
Dupree et al.,1998; Fremont-Smith et al.,2004; Papillo et al.,1998; Roberts et al.,1997). Besides, 
the leftover specimen for LBC can also be used for HPV DNA testing which is currently 
incorporated into the management guidelines and post-therapy surveillance of the patient in 
some institutes. Recently, a number of different LBC techniques are available worldwide. 
ThinPrep® and SurePath™ are prototypes of LBC technology. They have been approved by 
the Food and Drug Administration for cervical cancer screening in the USA and are the 
most commonly used LBC techniques (Bishop et al., 1998; Lee et al., 1997). LBC was 
introduced as a cervical cancer screening technique in Thailand in 1997. Nowadays there are 
at least three commercially available LBC in Thailand, e.g. ThinPrep®, SurePath™, and Liqui-
Prep®. Despite of their reputation, these LBC are still not in general use because of their cost. 
In the year 2005, we have developed an alcohol-based preservative solution, Siriraj liquid-
based solution, and applied a modified Saccomanno’s technique for cells preparation in our 
institute, and named this technology as the “Siriraj liquid-based cytology” or “Siriraj-LBC”. 
The collection of specimens for Siriraj-LBC is similar to that for conventional cytology, 
except that a special plastic spatula is used instead of the Ayre’s spatula and cotton swab. 
The plastic spatula has an extended endocervical tip at one end and a rounded rectangular 
tip at the other end, and scores at 4 cm from each end to facilitate spatula breaking (Figure 1). 
Immediately after cell collection, both ends of the spatula are manually broken at the scores, 
and put into a 30 mL plastic bottle containing 10 mL of Siriraj liquid-based solution. 
3.1 Processing of Siriraj-LBC 
The cell specimens are collected in bottles containing Siriraj liquid-based solution and keep 
at room temperature until processing. Siriraj-LBC slides are prepared according to the 
following steps (Bales, 2006) : agitate the bottle of specimen on a vortex mixer for 10 sec, and  
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Fig. 1. Collecting devices for Siriraj-LBC: a 30-mL plastic bottle containing 10 mL of Siriraj 
liquid-based solution (A), and an extended-tip plastic spatula, arrow heads showing scores 
on the spatula (B) 
pour the suspension into a 15-mL centrifuge test tube; centrifuge the specimen at 1000 g. for 10 
min, and discard the supernatant; add Siriraj liquid-based solution (approximately 3 times of 
the sediment volume); agitate the test tube for 10 sec, aspirate 15-20 μL of the sample by using 
an auto-pipette, drop the sample onto a clean glass slide, smear the droplet to 2 cm in 
diameter, and let air dry at room temperature for 30 min; fix the slide in 95% ethanol for 20 
minutes, and finally stain it with the routine Papanicolaou’s staining technique (Figure 2). 
3.2 Performance of Siriraj-LBC 
Before a new screening or diagnostic tool is introduced into clinical use, it is necessary to 
evaluate its diagnostic performance. The best way for this evaluation is to compare the 
result from the new tool with that from the gold standard, revealing the performance 
parameters including sensitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), false positive (FP), false negative (FN), and accuracy of the test. 
However, such parameters cannot be obtained in studies evaluating performance of cervical 
cytology methods because not all of the study population undergoes the gold standard 
testing, i.e. colposcopy or cervical histology. The gold standard is mostly lacking in the 
group of patients who have normal cervical cytology. Therefore, numerous studies have 
evaluated the comparative performance of the LBC methods and conventional cytology 
with respect to test positivity, i.e. the detection rate of squamous intraepithelial lesion (SIL). 
Most studies have utilized one to two types of study design, i.e. “split-sample” or “direct-to-
vial” study. With “split-sample” study, it is difficult to ensure that the two cytology 
specimens are comparable, since the specimen for conventional cytology slide is collected 
before the specimen for LBC. Therefore, this design seems to lead inherently to bias against 
LBC. With “direct-to-vial” study, the result of LBC is compared with that of conventional 
smear from historical data of an identical population; however, it is not certain that the two 
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Fig. 2. Stained slides of Siriraj-LBC and conventional smears (A); micrographs of cervical 
cytology at low magnification: conventional smear (B1), Siriraj-LBC smear (B2) 
populations are identical. The diagnostic performance of our home-made LBC has been 
evaluated in both the “split-sample” study and “direct-to-vial” study. 
3.3 A split-sample study (Laiwejpithaya et al., 2008) 
3.3.1 Study population and specimen processing 
A cross-sectional study was carried out in the Gynecologic Cytology Unit, Department of 
Obstetric and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University from 
January to February 2005. Study population were randomly selected from women attending 
for pelvic examination and cervical cancer screening at the Gynecologic Outpatient 
Department, Siriraj Hospital during the study period, excluding the women who had 
previously undergone any surgical procedures of the cervix, were pregnant or suspected of 
being pregnant, used any kinds of vaginal preparations within previous 24 hours, or denied 
to participate in the study. Specimens were collected for “split-sample” study by residents 
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Fig. 3. Micrographs of cervical cytology using Siriraj-LBC at high magnification: normal (A), 
atypical squamous cells of undetermined significance (B), atypical squamous cells cannot 
exclude HSIL (C), low-grade squamous intraepithelial lesion with koilocytosis (D), high-
grade squamous intraepithelial lesion (E), and squamous cell carcinoma (F) 
or gynecologists who were staff members of the Department of Obstetrics and Gynecology. 
The collected cells were initially prepared for conventional cytology. Leftover cells in the 
collecting instruments were then collected for Siriraj-LBC by putting the instruments into a 
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30 mL plastic bottle containing 10 mL of Siriraj liquid-based solution. Specimens for both 
techniques were transported to the Gynecologic Cytology Unit, and processed by 
experienced technicians. All of the slides were screened by a team of cytotechnologists. The 
abnormal slides were reviewed and diagnosis made by an experienced cytopathologist. 
Examples of various abnormal cervical cells are shown in Figure 3. Evaluation of slides for 
conventional cytology and Siriraj-LBC was made in a blind fashion, i.e. the interpretations of 
the results from one technique were made without knowledge of those from the other 
technique. The cytological interpretation was made according to the Bethesda system 2001 
as followed: negative for intraepithelial lesion or malignancy, reactive or reparative change, 
atypical squamous cells of undetermined significance (ASCUS), low-grade squamous 
intraepithelial lesion (LSIL), high grade squamous intraepithelial lesion (HSIL), atypical 
squamous cells cannot exclude HSIL (ASC-H), squamous cell carcinoma (SCC), atypical 
glandular cells (AGC), or adenocarcinoma (Solomon et al., 2002). Clinical management of 
abnormal cytology includes referral to colposcopy and treatment according to the guideline 
of Siriraj Hospital. The patients with cytology results of ASCUS or LSIL were suggested to 
have either colposcopy or repeat cervical cytology testing, and those with ASC-H, HSIL or 
more aggressive ones were referred to colposcopy. 
3.3.2 Performance of cytology as a screening test 
The performance of cytology was evaluated from detection rate of abnormal cervicovaginal 
cytology, and predictive values using colposcopy and/or histology as the gold standard. The 
data for calculating positive predictive value (PPV) were obtained from the patients who had 
abnormal results of Siriraj-LBC, and underwent operative procedures revealing histology. 
Those procedures included colposcopic directed cervical biopsy, loop electrosurgical excision 
procedure (LEEP), cold-knife conization, and hysterectomy. The data were presented in n (%), 
or odds ratio (OR) and 95% confidence interval (CI), as appropriate. Percentage of agreement 
was used to determine the diagnostic agreement between pairs of specimens evaluated by 
conventional cytology and Siriraj-LBC. Kappa and Spearman rho correlation coefficient were 
used to determine correlation of result between pairs of specimens. Chi-square test was used 
to compare frequency between the two cytology techniques. All tests were 2-sided, and a P 
value of less than 0.05 was considered statistically significant. 
3.3.3 Results 
There were 479 participants recruited during the study period. Their mean age was 
41.6+12.6 years. The Siriraj-LBC significantly increased overall detection rate of abnormal 
cytology compared to the conventional method, i.e. from 1.67% to 11.1%, P < 0.001 (Table 1). 
The data yielded a complete diagnostic agreement of 430 of 479 pairs of specimens (89.8%). 
Among these, HSIL was detected in both specimens in 2 cases and cancer in 1 case. There 
were 49 cases whose Siriraj-LBC revealed higher cytologic grading than the conventional 
cytology did; whereas, none of the conventional cytology showed the vise versa result. The 
highest disagreement was found in 18 cases which were interpreted as normal by 
conventional cytology, but as ASCUS by Siriraj-LBC. As a result, these two cytology 
techniques had minimal to fair correlation with a Kappa of 0.128 (P < 0.001) and a Spearman 
rho correlation coefficient of 0.394 (P < 0.001) (Table 2). 
Table 3 reveals final diagnoses by colposcopy or histology in 45 patients with abnormal 
cytological diagnoses by Siriraj-LBC. In this specific group, the Siriraj-LBC had a positive  
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Finding Conventional Siriraj-LBC P-value 
Overall 8 (1.67) 53 (11.1) <0.001 
ASCUS 2 (0.42) 18 (3.76)  
ASC-H 1 (0.21) 7 (1.46)  
LSIL 2 (0.42) 15 (3.13)  
HSIL 2 (0.42) 10 (2.09)  
Cancer 1 (0.21) 3 (0.63)  
[Data are n (%). The data were analyzed using Fisher’s exact test.] 
From Laiwejpithaya, S.; Rattanachaiyanont, M.; Benjapibal, M.; Khuakoonratt, N.; Boriboonhirunsarn, 
D.; Laiwejpithaya, S.; Sangkarat, S.; & Wongtiraporn, W. (2008). Comparison between Siriraj liquid-
based and conventional cytology for detection of abnormal cervicovaginal smears: A split-sample 
study. Asian Pacific J Cancer Prev, Vol.9, No.4, pp. 575-580. 
Table 1. Detection Rates of Abnormal Cervical Cytology by Conventional Cytology and 
Siriraj-LBC 
 
Siriraj-LBC Conventional cytology 
 Negative ASCUS ASC-H LSIL HSIL Cancer 
Negative 426 0 0 0 0 0 
ASCUS 18 0 0 0 0 0 
ASC-H 7 0 0 0 0 0 
LSIL 12 2 0 1 0 0 
HSIL 6 0 1 1 2 0 
Cancer 2 0 0 0 0 1 
(Data are number of cases. Identical diagnoses are shown in bold; cases with negative diagnosis by 
conventional cytology but abnormal diagnoses by Siriraj-LBC are in red; Spearman rho correlation = 
0.394, Kappa = 0.128, P <0.001.) 
From Laiwejpithaya, S.; Rattanachaiyanont, M.; Benjapibal, M.; Khuakoonratt, N.; Boriboonhirunsarn, 
D.; Laiwejpithaya, S.; Sangkarat, S.; & Wongtiraporn, W. (2008). Comparison between Siriraj liquid-
based and conventional cytology for detection of abnormal cervicovaginal smears: A split-sample 
study. Asian Pacific J Cancer Prev, Vol.9, No.4, pp. 575-580. 
Table 2. Comparison of Cytological Diagnoses between Conventional Cytology and Siriraj-
LBC in 479 Pairs of Samples 
predictive value (PPV) of 71.1% whereas conventional cytology had PPV and negative 
predictive value (NPV) of 85.7% and 31.6%, respectively. None of the ASCUS had cervical 
lesions beyond CIN1. Seven cases of ASC-H was found in Siriraj-LBC but only one in 
conventional cytology; one in seven (14.28%) of ASC-H had cervical lesion of CIN2/3. The 
Siriraj-LBC did not miss any high grade cervical lesions (CIN2/3 or cancer) but over-
diagnosed cancer in one case; whereas conventional cytology failed to detect 3/6 (50%) cases 
of CIN2/3 and 1/2 (50%) cases of cancer. 
3.3.4 Discussion 
The present study used the data of the year 2005 when the Siriraj-LBC was undergoing the 
development process. We found that the detection rate of abnormal cells in Siriraj-LBC 
(11.06%) was much higher than that in the conventional cytology (1.67%). Even though the 
“split-sample” study has potential bias against LBC, we were not encountered with this 
problem. It was possible that the specimen processing in the Siriraj-LBC, especially the  
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Cytology Diagnoses by Colposcopy or Histology
 Normal CIN1/HPV CIN2/3 Cancer 
Conventional   
Negative 12 22 3 1b 
ASCUS 1 1 0 0 
ASC-H 0 0 1 0 
LSIL 0 0 1 0 
HSIL 0 1 1 0 
Cancer 0 0 0 1c 
Siriraj-LBC   
Negative NA NA NA NA 
ASCUS 7 9 0 0 
ASC-H 3 3 1 0 
LSIL 1 8 0 0 
HSIL 1 4 5 0 
Cancer 1a 0 0 2b,c 
(Cytological vs. histological diagnoses: aadenocarcinoma of endometrium vs normal, badenocarcinoma 
of unknown origin vs. adenocarcinoma of peritoneum, and cadenocarcinoma of endometrium vs. 
squamous cell carcinoma. CIN = cervical intraepithelial neoplasia, HPV = human papilloma virus 
infection, NA = not applicable) 
From Laiwejpithaya, S.; Rattanachaiyanont, M.; Benjapibal, M.; Khuakoonratt, N.; Boriboonhirunsarn, 
D.; Laiwejpithaya, S.; Sangkarat, S.; & Wongtiraporn, W. (2008). Comparison between Siriraj liquid-
based and conventional cytology for detection of abnormal cervicovaginal smears: A split-sample 
study. Asian Pacific J Cancer Prev, Vol.9, No.4, pp. 575-580. 
Table 3. Final Diagnoses by Colposcopy or Histology in 45 patients with Abnormal 
Cytological Diagnoses 
agitation of collecting devices in the liquid-based solution would elude the entrapped cells 
into the solution, therefore more cells were collected into the solution, and then evenly 
sampling to put onto a glass slide. We found that the complete diagnostic agreement 
between our LBC and the standard cytology was in high level (89.77%). However, the 
Kappa and the correlation coefficient were not in that high level; this was due to the 
interesting fact that detection rate of abnormal cells was much higher in the Siriraj-LBC than 
in the conventional cytology. Our result was comparable with that of Park et al (2001) 
showing that the results of conventional cytology and LBC exactly agreed in 91.4% of cases. 
The increase in detection rate raised the concern of increase in false positive cytology. In the 
present study, 45 cases of the abnormal cytology detected by Siriraj- LBC undergone gold 
standard testing. We found that the overall PPV in the Siriraj-LBC was less than that in the 
conventional cytology (71.1% vs. 85.7%). This implied that the Siriraj-LBC increase false 
positive result from 7.7% to 100.0%. In this specific group of patients with positive result by 
Siriraj-LBC, the conventional cytology had an astounding high false negative result of 81.2%. 
The false negative result of Siriraj-LBC was unknown because none of the patients with 
negative cytology undergone gold standard testing, despites, we assumed that the Siriraj-
LBC would have less false negative result since none of the negative Siriraj-LBC had 
abnormal conventional cytology. However, we are aware that these numbers are not the real 
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false negative and false positive rates, as the actual rates cannot be obtained due to the 
limitation of this kind of study. 
The high false positive result by Siriraj-LBC caused only little concern. Considering that only 
HSIL or cancer needs further invasive investigation, e.g. conization and/or diagnostic 
curettage, two in 45 cases had risk of unnecessary further investigation if the Siriraj-LBC was 
used in place of conventional cytology; this risk returned with the benefit of detecting three 
more cases of CIN2/3 and one case of cancer which were cases with false negative result in 
the conventional cytology. Noteworthy, the missing cancer in conventional cytology was a 
case of peritoneal adenocarcinoma without lesion at the uterine cervix. 
Our limited data showed that the conventional cytology had high false negative result 
where as the Siriraj-LBC had high false positive result. It is estimated that approximately 
two thirds of false negative result in the conventional cytology are caused by sampling error 
due to limited transfer of cells from the collecting device onto the slide (Gay et al., 1985). The 
false positive result in the Siriraj-LBC was due to the increase in all types of abnormal 
epithelial cells. This may be due to the misinterpretation of immature squamous metaplastic 
or atrophic cells to be abnormal cells because the morphologies of these cells are alike. 
Moreover these cells could be more easily detected in the Siriraj-LBC than in the 
conventional cytology because of the better quality of slide. However, we could not 
disregard the fact that our novice in the LBC field also contributed to this false positive. We 
expect to get better results of this technique in the future. 
Our result was compatible with many previous reports. Nanda et al (2000) reviewed the 
accuracy of conventional and new methods of Papanicolaou (Pap) testing to detect cervical 
cancer and its precursors. Ninety-four studies of the conventional Pap test showed that, 
estimates of sensitivity and specificity varied greatly in individual studies. In the 12 studies 
with the least biased, estimates sensitivity ranged from 30-80% and specificity ranged from 
86-100%. Guo et al (2005) evaluated the accuracy of a LBC test, ThinPrep®, by comparing 
concurrent LBC and cervical biopsy results of 782 patients who were referred for colposcopy 
because of previously abnormal conventional cytology. They found that concurrent LBC has 
high diagnostic accuracy for SIL. Besides, several studies showed that the detection rates of 
LSIL and HSIL are improved by LBC but the effect of LBC on the detection of ASC-US is 
uncertain (Limaye et al., 2003; Mount et al., 2004). 
The results from Siriraj-LBC and conventional cytology have high diagnostic agreement and 
minimal to fair correlation. The Siriraj-LBC increases detection rate of abnormal 
cervicovaginal cells with probably decrease false negative but increase false positive from 
the baseline values by conventional cytology. Therefore the screening performance of Siriraj-
LBC is not inferior to the conventional cytology and may be used as an alternative screening 
method for cervical cancer. 
3.4 A direct-to-vial study (Laiwejpithaya et al., 2009) 
3.4.1 Study population and specimen processing 
The study was carried out in the Gynecologic Cytology Unit, Department of Obstetrics and 
Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University. Data were retrieved 
from the database of the Gynecologic Cytology Unit. The data of conventional cytology and 
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LBC were recruited from records of the years 2004 and 2006, respectively. The specimens for 
either conventional cytology or LBC were obtained from patients who had pelvic 
examination at the Gynecologic Outpatient Department of Siriraj Hospital during the 
relevant study periods. Specimens were collected by residents and staff members of the 
Department of Obstetrics and Gynecology. Collection of specimens for conventional 
cytology was performed according to the standard VCE smear technique. The collection of 
specimens for Siriraj-LBC was similar to that for conventional cytology, except that a special 
plastic spatula was used instead of the Ayre’s spatula and cotton swab. All specimens were 
transported to the Gynecologic Cytology Unit, and processed by experienced technicians. 
All of the slides were screened by a team of cytotechnologists and the abnormal slides were 
reviewed and diagnosis made by an experienced cytopathologist. Clinical management of 
abnormal cytology includes referral to colposcopy and treatment according to the guideline 
of Siriraj Hospital as mentioned above. 
3.4.2 Performance of cytology as a screening test 
The performance of Siriraj-LBC was evaluated from the detection rate of abnormal cervical 
cytology, and predictive values using cervical histology as the gold standard. The data for 
calculating negative predictive value (NPV) were obtained from the patients who had 
normal results of pre-hysterectomy screening cervical cytology. The data for calculating 
positive predictive value (PPV) were obtained from the patients who had abnormal results 
of cervical cytology and underwent operative procedures revealing cervical histology. Those 
procedures included colposcopic directed cervical biopsy, loop electrosurgical excision 
procedure (LEEP), cold-knife conization, and hysterectomy. Normal cervical histology was 
considered when the cervical mucosa was clear from any neoplastic lesion, ignoring the 
histopathological result of endometrium. The data were presented as mean+standard 
deviation (SD), n (%), or % change, as appropriate. Data were analyzed using the t-test for 
continuous data or Chi-square test for categorical data. All tests were 2-sided, and a P-value 
of  < 0.05 was considered statistically significant. 
3.4.3 Results 
There were 23,676 records of conventional Papanicolaou’s smear and 25,510 records of 
Siriraj-LBC in the years 2004 and 2006, respectively. Almost all of the specimens came from 
Thai women. The mean age+SD of women in the years 2004 and 2006 were 40.67+12.54 and 
42.66+12.21 years, respectively, which were not statistically different. Compared with the 
conventional smear, the Siriraj-LBC significantly increased overall detection rate of 
abnormal cytology by 110.23% (from 1.76% to 3.70%, P < 0.001), as it increased the detection 
rate of ASCUS, LSIL, HSIL, ASC-H, and malignant cells, but it did not significantly increase 
the detection rate of atypical glandular cells (AGC). The Siriraj-LBC significantly reduced 
the number of smears that were deemed poor quality by 73.44% (from 18.60% to 4.94%, P < 
0.001), as it markedly decreased the smears with obscuring blood and inflammatory cells, 
thick smears (Fig. 1b and c), and the smears without transformation zone component. 
However, the Siriraj-LBC had a marked increase in scant cellular smears (Table 4). 
The predictive value of Siriraj-LBC was better than that of conventional smear. The NPV of 
Siriraj-LBC was apparently higher than that of conventional cytology (96.33% vs. 92.74%,  
P = 0.001). The PPV of both methods was > 80%, which did not demonstrate any significant  
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Siriraj-LBC 
(N= 25,510) 
Conventional 
(N= 23,676) 
% change P 
All abnormal cervical cells 944 (3.70) 417 (1.76) +110.23 <0.001 
ASCUS 251 (0.98) 100 (0.42) +133.33 <0.001 
LSIL 278 (1.09) 132 (0.56) +94.64 <0.001 
HSIL 213 (0.83) 94 (0.40) +107.50 <0.001 
ASC-H 117 (0.46) 41 (0.17) +170.59 <0.001 
AGC 25 (0.10) 16 (0.07) +42.86 0.243 
Malignant 60 (0.24) 34 (0.14) +71.43 0.020 
All poor quality slides 1261 (4.94) 4404 (18.60) -73.44 <0.001 
No transformation zone 
component 
1094 (4.29) 3766 (15.91) -73.04 <0.001 
Scant cellular smears 153 (0.60) 51 (0.22) +172.73 <0.001 
Thick smears 2 (0.01) 212 (0.90) -98.89 <0.001 
Obscuring blood and 
inflammatory cells 
12 (0.05) 375 (1.58) -96.84 <0.001 
[Note: Data are n (%). Percent change was the incremental (+) or decremental (_) rate of Siriraj-LBC 
comparing to the baseline rate of conventional cytology. The data were analyzed using Chi-square test.] 
From Laiwejpithaya, S.; Benjapibal, M.; Laiwejpithaya, S.; Wongtiraporn, W.; Sangkarat, S.; & 
Rattanachaiyanont, M.  (2009). Performance and cost analysis of Siriraj liquid-based cytology: a direct-
to-vial study. Eur J Obstet Gynecol Reprod Biol, Vol. 147, No.2, pp. 201-205. 
Table 4. Detection rates of abnormal cervical cells and quality of slides using Siriraj liquid-
based cytology (Siriraj-LBC, year 2006) and conventional Papanicolaou’s smear (year 2004) 
difference between the methods. The PPV for SCC was the highest; whereas that for 
abnormal glandular cell types was the lowest (Table 5). The cost of Siriraj-LBC was higher 
than that of the conventional cytology used in Siriraj Hospital but lower than that of the 
commercially available LBC in Thailand. When cost was estimated from the laboratory 
charge, it was found that the cost of Siriraj-LBC was 1.67, 0.50, and 0.30 times of those of the 
conventional cytology, Liqui-Prep®, and ThinPrep®, respectively (Table 6). 
 
Cervical cytology N Cervical histology, n (%) P 
  Normal Abnormal  
Normal     
Siriraj-LBC 1012 975 (96.33)(a) 37 (3.67) 0.001 
Conventional 744 690 (92.74) (a) 54 (7.26)  
Overall abnormalitie     
Siriraj-LBC 277 47 (16.97) 230 (83.03)(b) 0.285 
Conventional 167 22 (13.17) 145 (86.83)(b)  
ASCUS     
Siriraj-LBC 13 7 (53.85) 6 (46.15)(b) 0.342 
Conventional 9 3 (33.33) 6 (66.67)(b)  
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Cervical cytology N Cervical histology, n (%) P 
  Normal Abnormal  
LSIL     
Siriraj-LBC 41 6 (14.63) 35 (85.37)(b) 0.597 
Conventional 29 3 (10.34) 26 (89.66)(b)  
HSIL     
Siriraj-LBC 124 10 (8.06) 114 (91.94)(b) 0.301 
Conventional 71 3 (4.23) 68 (95.77)(b)  
ASC-H     
Siriraj-LBC 33 4 (12.12) 29 (87.88)(b) 0.579 
Conventional 23 4 (17.39) 19 (82.61)(b)  
SCC     
Siriraj-LBC 26 0 (0.00) 26 (100.00)(b) 0.183 
Conventional 15 1 (6.67) 14 (93.33)(b)  
Abnormal glandular cell types (AGC+AIS+Adenocarcinoma)   
Siriraj-LBC 40 20 (50.00) 20 (50.00)(b) 0.464 
Conventional 20 8 (40.00) 12 (60.00)(b)  
[Note: Data are n (% of the corresponding row). The data were analyzed using Chisquare test. 
Abnormal cervical histology meant cervical tissue specimen showing intraepithelial neoplasia, 
squamous cell carcinoma, or adenocarcinoma. (a) Negative predictive value; (b) positive predictive 
value; AGC, atypical glandular cells; AIS, adenocarcinoma in situ; ASCUS, atypical squamous cells of 
undetermined significance; ASC-H, atypical squamous cells cannot exclude HSIL; CI, confidence 
interval; LSIL, low grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial 
lesion; SCC, squamous cell carcino] 
From Laiwejpithaya, S.; Benjapibal, M.; Laiwejpithaya, S.; Wongtiraporn, W.; Sangkarat, S.; & 
Rattanachaiyanont, M.  (2009). Performance and cost analysis of Siriraj liquid-based cytology: a direct-
to-vial study. Eur J Obstet Gynecol Reprod Biol, Vol. 147, No.2, pp. 201-205. 
Table 5. Predictive values of cervical cytology using Siriraj liquid-based cytology (Siriraj-
LBC, year 2006) and conventional Papanicolaou’s smear (year 2004) 
 
Costs Thai baht US dollars 
Siriraj liquid-based cytology 150.00 4.55 
Siriraj conventional cytology 90.00 2.72 
Commercially available liquid-based cytology techniques   
Liqui-Prep® 300.00 9.09 
ThinPrep® 500.00 15.15 
From Laiwejpithaya, S.; Benjapibal, M.; Laiwejpithaya, S.; Wongtiraporn, W.; Sangkarat, S.; & 
Rattanachaiyanont, M.  (2009). Performance and cost analysis of Siriraj liquid-based cytology: a direct-
to-vial study. Eur J Obstet Gynecol Reprod Biol, Vol. 147, No.2, pp. 201-205. 
Table 6. Costs of Siriraj liquid-based cytology, conventional cytology at Siriraj Hospital, and 
commercially available liquid-based cytology techniques in Thailand 
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3.4.4 Discussion 
In the present direct-to-vial study, we compared the data of patients undergoing specimen 
collection for cervical cytology by the same physician group in two 12-month periods, 
targeting conventional Papanicolaou’s smear in 2004 and Siriraj-LBC in 2006. As expected, 
the Siriraj-LBC increased detection of precancerous lesions of the uterine cervix. From our 
previous split-sample study conducted during the development of this technology in 2005, 
the Siriraj-LBC showed a tremendously increased detection rate of abnormal cytology of 
565%, from 1.67% to 11.10%. However, the increase in the detection rate decreased to 100% 
in 2006 when the Siriraj-LBC was routinely used. The huge increase in 2005 was probably 
due to rigorous examination of slides during the development of the new technology. The 
increase in 2006 was less pronounced but still impressive even though the slides were 
routinely examined in the same manner as they were in 2004. 
The increase in detection rate of Siriraj-LBC was probably due to the benefit of improved 
slide quality. Whereas 18.60% of our conventional smears had limited quality due to no 
endocervical or transformation zone component, obscuring blood and inflammatory cells, 
thick smear, or scant cellular smears, only 4.94% of the Siriraj-LBC had smears limited by 
these factors. Our results were in line with the experience of others (Bolick et al.,1998; 
Corkill et al.,1998; Diaz-Rosario et al.,1999; Dupree et al.,1998; Fremont-Smith et al.,2004; 
Papillo et al.,1998; Roberts et al.,1997). The improvement in the quality of slides in 2006 is 
likely to be due to the property of Siriraj- LBC itself rather than other factors, since the 
detection rate and quality of slides before 2005 had never reached those of the slides in 2006. 
Our 3-year retrospective data from 2002 to 2004 showed that our conventional smears had 
detection rates varying from 1.7% to 2.1%, and the poor quality smears varying from 18.6% 
to 32.6%. 
The better detection rate of intraepithelial lesions is a common thread in studies on liquid-
based cervical cytology. The increase in detection rates in previous studies varied from 
12.0% to 106.8% (Bolick et al.,1998; Corkill et al.,1998; Diaz-Rosario et al.,1999; Dupree et 
al.,1998; Fremont-Smith et al.,2004; Papillo et al.,1998; Roberts et al.,1997). The reason for the 
wide range of this effect is not clear; but a wide range in detection rates of intraepithelial 
lesions by the conventional smear is also noted in the same studies, i.e. 1.1–2.7%. The 
increment seems higher in the studies with a low baseline detection rate using the 
conventional smear. In addition, this variation may represent regional or population-based 
differences, or different practice patterns. In our direct-to-vial study, Siriraj-LBC had a 100% 
increment for the detection of SIL from a baseline rate of 0.96% (LSIL = 0.56% and HSIL = 
0.40%). The overwhelming diagnostic improvement of Siriraj-LBC, especially with respect to 
HSIL detection, would enhance the success of cervical cancer screening in our institute. 
Owing to the fact that the LBC slide makes it easier for a cytologist to find small numbers of 
abnormal cells, the percentages of ASCUS and ASC-H were also higher with Siriraj-LBC 
compared with the conventional method. The results were welcomed by the gynecologists 
who were chronically in fear of false negative results. 
The increase in detection rate came with the concern of an increase in false positive cytology. 
From our cytology-histology paired data, Siriraj-LBC increased NPV without compromising 
PPV. This information implied that the Siriraj-LBC decreased false negative results, i.e. from 
7.26% to 3.67% (P = 0.001) without affecting the overall false positive result, i.e. 13.17% vs. 
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16.97% (P = 0.285). However, we were aware that these numbers were not the real false 
negative and false positive rates, as the actual rates could not be obtained due to the 
limitations of this kind of study. The Siriraj-LBC displayed a higher false positive HSIL than 
the conventional method did, probably due to the morphological resemblance of immature 
squamous metaplastic or atrophic cells to HSIL. As these cells were easier to detect in the 
Siriraj-LBC than in the conventional smear, the higher false positive HSIL was not 
unexpected. However, as discussed in the split-sample study, we could not disregard the 
fact that our being novices in the LBC field could contribute to this false positivity. We 
expect to get better results using this technique in the future. 
When the laboratory cost of the various cervical cytology techniques was calculated, we 
found that the cost of Siriraj-LBC was only 67% higher than that of the conventional 
cytology technique used in Siriraj Hospital and was lower than that of the commercially 
available LBC techniques in Thailand. However, we did not directly compare the diagnostic 
performance among the LBC techniques; therefore we did not know which LBC technology 
was the most cost-effective for our population. Nevertheless, because of its low cost and 
better performance than conventional cytology, Siriraj-LBC would be an accessible LBC 
technology for women of low-socioeconomic level. As a result, Siriraj-LBC has replaced the 
conventional cytology in Siriraj Hospital  since 2006. 
The Siriraj-LBC shows an impressive improvement in the detection rate of abnormal cervical 
cells. The Siriraj-LBC has an acceptable performance and quality which are within the same 
range as other previously reported LBC techniques. Therefore, the Siriraj-LBC may be 
considered a better option for cervical cancer screening than the conventional method and 
more economical than the commercially available LBC. 
4. Conclusion 
The diagnostic performance of our home-made LBC has been evaluated in both the “split-
sample” study and “direct-to-vial” study and we have found that the screening performance 
of Siriraj-LBC was superior to that of conventional cytology. Our LBC does not require any 
expensive equipment; therefore its cost is much less than that of the commercial ones. 
Siriraj-LBC may be considered a better option for cervical cancer screening than the 
conventional method. For centers where conventional Pap smear does not perform well, the 
introduction of a low cost Siriraj-LBC may help to improve performance. We believe that the 
Siriraj-LBC will make a significant change in cervical cancer screening and patient 
management in our country. 
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